Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
28.38
-0.90 (-3.07%)
At close: Oct 6, 2026, 4:00 PM EDT
28.54
+0.16 (0.56%)
After-hours: Oct 6, 2026, 7:58 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 65 employees as of June 30, 2026. The number of employees increased by 16 or 32.65% compared to the same quarter last year.
Employees
65
Change
16
Growth
32.65%
Revenue / Employee
n/a
Profits / Employee
-$8,227,631
Market Cap
3.31B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Acadia Pharmaceuticals | 798 |
| Denali Therapeutics | 507 |
| Xenon Pharmaceuticals | 370 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Celcuity | 155 |
VKTX News
- 20 hours ago - Viking Therapeutics initiates oral maintenance dosing study of VK2735 - TheFly
- 20 hours ago - Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity - PRNewsWire
- 4 days ago - 3 Best Growth Stocks to Buy Now with 55%+ Upside, According to Analysts - TipRanks
- 8 days ago - Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes - PRNewsWire
- 12 days ago - Viking Therapeutics falls -14.0% - TheFly
- 12 days ago - Viking Therapeutics falls -13.1% - TheFly
- 12 days ago - Viking Therapeutics 7.86M share Spot Secondary priced at $35.00 - TheFly
- 12 days ago - Viking Therapeutics 7.857M share Spot Secondary priced at $35.00 - TheFly